Doctolib has raised $895M across 3 funding rounds. The company is valued at $6.4B (post-money).
Doctolib raised $550 million in March 2022 in a round led by Eurazeo, valuing the company at $6.4 billion, and its total funding stands at $815 million. Eurazeo remains a shareholder in the company, and the round funded expansion of its all-in-one healthcare platform beyond France.
3 funding rounds, the latest highlighted.
Doctolib was founded in 2013, France.
A primary round — the company sells new shares to investors it selects.
A primary round — the company sells new shares to investors it selects. $550M raised, led by Eurazeo.
No filing has been made.
3 dated rounds, newest first.
EurazeoLEAD
Bpifrance
General Atlantic
Accel PartnersThe last valuation is $6.4B.
Lead investors for each round are in the funding timeline.
The closest healthtech / medical appointment booking peers are on the competitors page.
The routes section explains what is realistically available for a company at this stage.
Perpetual markets for stocks, gold, indices and pre-IPO names — settled on-chain, no wallet-to-exchange transfers.
